期刊文献+

磷脂酰肌醇蛋白聚糖-3基因对肝癌细胞SK-Hep-1黏附和侵袭的影响 被引量:3

Influence of glypican-3 gene on proliferation,adhesion and invasion of hepatoma carcinoma cancer cell line SK-Hep-1
暂未订购
导出
摘要 目的:肝细胞癌中高表达磷脂酰肌醇蛋白聚糖-3基因(glypican-3,GPC3),而在非肿瘤肝组织、肝细胞腺瘤、胆管癌、肝内胆管细胞癌、胆囊癌等细胞中低表达甚至不表达;本研究利用携带GPC3重组真核表达载体,探讨GPC3基因对SK-Hep-1肝癌细胞增殖、黏附和侵袭能力的影响。方法:将pEGFP-N2-GPC3通过脂质体方法转染人肝癌细胞SK-Hep-1。RT-PCR检测GPC3-SK-Hep-1细胞中GPC3mRNA的表达;MTT法检测SK-Hep-1细胞的增殖并计算黏附率;Transwell小室实验检测SK-Hep-1肝癌细胞的迁移能力和侵袭能力。结果:pEGFP-N2-GPC3成功转染SK-Hep-1细胞,转染后GPC3-Hep-1细胞明显表达GPC3mRNA。GPC3转染能显著抑制肝癌细胞SK-Hep-1的增殖(P<0.01);GPC3转染细胞的黏附能力较对照细胞显著下降[(10.21±0.62)%vs(15.51±0.95)%,P<0.01];GPC3转染细胞的迁徙和侵袭能力较对照细胞明显增强[(131.7±7.44)vs(69.6±5.25),P<0.01;(220±12.8)vs(130±8.2),P<0.01]。结论:GPC3基因显著抑制肝癌细胞的增殖和黏附能力,但显著增强后者的迁移和侵袭能力。 Objective: To study the influence of GPC3 gene on the proliferation, adhesion and invasion of hepatoma cell line SK-Hep-1. Methods: SK-Hep-1 cells were transfected with pEGFP-N2-GPC3 using Lipofectamine2000. RT-PCR was used to examine the GPC3mRNA expression in GPC3-SK-Hep-1 cells. MTT assay was used to examine the proliferation and calculate the adhesion rate of SK-Hep-1 cells. Transwell system was used to assess the migration and invasion of the cells. Results: SK-Hep-1 cells were successfully transfected with pEGFP-N2-GPC palsmid. GPC3 mRNA was detected in SK-Hep-1 cells. Transfeetion with CPC3 significantly suppressed the growth of SK-Hep-1 cells (P 〈 0.01 ). The adhesion ability of GPC3-transfected cells was significantly decreased compared with control group( [ 10.21 ±0.62 ] % vs [ 15. 51 ± 0. 95 ] % , P 〈 0. 01 1. Transfection with GPC3 significantly enhanced migration and invasion capacity ( [ 131.7 ± 7.44 ] vs [ 69.6± 5.25 ] ,P 〈 0.01 ; [ 220± 12.8 ] vs [ 130±8.2 ], P 〈 0.01 ]. Conclusion: Transfection with GPC3 gene can greatly inhibit the proliferation and adhesion of hepatoma SK-Hep-1 cells, but can enhance their migration and invasiveness. The present study provides an experimental basis for studying the invasion mechanism of liver cancer.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2008年第5期474-477,483,共5页 Chinese Journal of Cancer Biotherapy
基金 福建省青年科技人才创新项目(No.2005J074)~~
关键词 磷脂酰肌醇蛋白聚糖-3 SK-Hep-1肝癌细胞 侵袭 黏附 增殖 glypican-3 ( GPC3 ) SK-Hep-1 hepatoma carcinoma cell Invasion proliferation
  • 相关文献

参考文献16

  • 1Yamauchi N, Watanabe A, Hishinuma M, et al. The glypican 3 oncofetal protein is a promising diagnostic marker for hepetocellular carcinoma[ J]. Mod Pathol, 2005, 18(12) :1591-1598.
  • 2Hippo Y , Watanabe K , Watanabe A , et al . Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatoeelluar carcinoma[J]. Cancer Res, 2004, 64 ( 7 ) : 2418-2423.
  • 3ChengLiao,Mu-junZhao,JingZhao,HaiSong,PascalPineau,AgnésMarchio,AnneDejean,PierreTiollais,Hong-YangWang,Tsai-PingLi.Mutation analysis of novel human liver-related putative tumor suppressor gene in hepatocellular carcinoma[J].World Journal of Gastroenterology,2003,9(1):89-93. 被引量:67
  • 4Sung YK, Hwang SY, Park MK, et al. Glypican-3 is overex- pressed in human hepatocellular carcinoma [ J ]. Cancer Sci, 2003, 94 (3) : 259-262.
  • 5Midorikawa Y, Ishikawa S, Iwanari H, et al. Glypican-3, over expressed in hepatocelluar carcinoma, modul-ates FGF2 and BM P-7 signaling[J]. Int J Cancer, 2003, 103(4) :455465.
  • 6Kwaek MH, Choi BY, Sung YK. Cellular changes resulting from rorced expression of glypican-3 in hepatocellular carcinoma cells [J]. MolCells, 2005, 21(2): 224-228.
  • 7胡春霞,翁丹卉,蒋学锋,朱涛,李红雨,何超蔓,卢运萍,王世宣,马丁.肿瘤转移抑制基因KAI1对子宫内膜癌细胞增殖、侵袭能力的影响[J].中国肿瘤生物治疗杂志,2007,14(5):445-449. 被引量:2
  • 8Jiang WJ, Man XB, Tang L, et al. Gradual upregulation of 0CI-5 expression during occurrence and progression of rat hepatoeellular carcinoma[ J]. Hepatobiliary Panereat Dis Int, 2006, 5 (2) : 257- 261.
  • 9Farooq M, Hwang SY, Park MK, et al. Blocking endogenous glypican-3 expression releases Hep3B cells from GI arrest [J]. Mol Cells, 2003, 15(3) : 356-360.
  • 10Sung YK, Hwang SY, Farooq M, et al. Growth promotion of HepG2 hepatoma ceils by antisense-mediated knockdown of glypican-3 is independent of insulin-like growth factor 2 signaling[ J]. Exp Mol Med, 2003, 35(4) : 257-262.

二级参考文献20

  • 1Xiu-Sheng He Qi Su Zhu-Chu Chen Xiu-Tao He Zhi-Feng Long Hui Ling Liang-Run Zhang Oncology Institute,Nanhua University,Hengyang 421001,Hunan Province,ChinaOncology Institute,Center South University,Changsha 410078,Hunan Province,China Department of Gastroenterology,First People’s Hospital of Changde City,Changde 415003,Hunan Province,China.Expression,deleton and mnutation of ρ16 gene in human gastric cancer[J].World Journal of Gastroenterology,2001,7(4):515-521. 被引量:40
  • 2PENG Xiao Mou, YAO Chun Lan, CHEN Xue Juan, PENG Wen Wei and GAO Zhi Liang.Codon 249 mutations of p53 gene in non-neoplastic liver tissues[J].World Journal of Gastroenterology,1999,5(4):52-54. 被引量:11
  • 3胡春霞,周金华,蒋学锋,刘荣华,翁丹卉,卢运萍,王世宣,马丁.肿瘤转移抑制基因KAI1在子宫内膜癌原发灶和转移灶组织中的表达及其临床意义[J].现代妇产科进展,2007,16(7):492-495. 被引量:3
  • 4萨姆布鲁克J 弗里奇EF 曼尼阿蒂斯T 金冬雁 黎盂枫 译.分子克隆实验指南[M](第2版)[M].北京:科学出版社,1992..
  • 5Pilia G,Hughes-Benzie RM,MacKenzie A,et al.Mutations in GPC3,a glypican gene,cause the Simpson-Golabi-Behmel overgrowth syndrome.Nat Genet,1996,12(3):241.
  • 6Capurro M,Wanless IR,Sherman M,et al.Glypican-3:a novel serum and histochemical marker for hepatocellular carcinoma.Gastroenterology,2003,125(1):89.
  • 7Nakatsura T,Kageshita T,Ito S,et al.Identification of glypican-3 as a novel tumor marker for melanoma.Clin Cancer Res,2004,10(19):6612.
  • 8Kim H,Xu GL,Borczuk AC,et al.The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor.Am J Respir Cell Mol Biol,2003,29(6):694.
  • 9Xiang YY,Ladeda V,Filmus J.Glypican-3 expression is silenced in human breast cancer.Oncogene,2001,20(50):7408.
  • 10Lin H,Huber R,Schlessinger D,et al.Frequent silencing of the GPC3 gene in ovarian cancer cell lines.Cancer Res,1999,59(4):807.

共引文献69

同被引文献53

  • 1Filmus J, Capurro M. Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma. Mol Diagn 2004; 8: 207-212.
  • 2Shirakawa H, Suzuki H, Shimomura M, Kojima M, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kobayashi N, Kinoshita T, Nakatsura T. Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma. Cancer Sci 2009; 100: 1403-1407.
  • 3Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Forabosco A, Schlessinger D. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet 1996; 12:241-247.
  • 4Lapunzina P. Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am ] Med Genet C Semin Med Genet 2005; 137C: 53-71.
  • 5Liu B, Paranjpe S, Bowen WC, Bell AW, Luo JH, Yu YP, Mars WM, Michalopoulos GK. Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation. Am J Pathol 2009; 175: 717-724.
  • 6Lai JP, Sandhu DS, Yu C, Han T, Moser CD, Jackson KK, Guerrero RB, Aderca I, Isomoto H, Garrity- Park MM, Zou H, Shire AM, Nagorney DM, Sanderson SO, Adjei AA, Lee JS, Thorgeirsson SS, Roberts LR. Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma. Hepatology 2008; 47:1211-1222.
  • 7Morford LA, Davis C, Jin L, Dobierzewska A, Peterson ML, Spear BT. The oncofetal gene glypican 3 is regulated in the postnatal liver by zinc fingers and homeoboxes 2 and in the regenerating liver by alpha-fetoprotein regulator 2. Hepatology 2007; 46: 1541-1547.
  • 8Lv Z, Zhang M, Bi J, Xu F, Hu S, Wen J. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma. Am J Clin Pathol.2006; 125: 740-746.
  • 9Kwack MH, Choi BY, Sung YK. Cellular changes resulting from forced expression of glypican-3 in hepatocellular carcinoma cells. Mol Cells 2006; 21: 224-228.
  • 10Kittaka N, Takemasa I, Takeda Y, Marubashi S, Nagano H, Umeshita K, Dono K, Matsubara K, Matsuura N, Monden M. Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data. Eur J Cancer 2008; 44:885-897.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部